Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Turkington, Richard
DECIPHER, NCT05965479: Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer	Recruiting	2	25	Europe	Trastuzumab deruxtecan, Enhertu	University of Southampton, AstraZeneca, Natera, Inc.	Gastrooesophageal Cancer	03/26	04/28
NCT04305067: PRECISE: Pancreatic Cancer and Exercise	Completed	N/A	8	Europe	Exercise	Queen's University, Belfast, Pancreatic Cancer UK, Belfast Health and Social Care Trust	Pancreas Adenocarcinoma	07/22	08/22
NCT04161417: Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer	Recruiting	N/A	2500	Europe	Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling	Judith Dixon-Hughes, Cancer Research UK, NHS Greater Glasgow and Clyde	Neoplasms Pancreatic	12/25	12/25
Tween, Hannah
DECIPHER, NCT05965479: Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer	Recruiting	2	25	Europe	Trastuzumab deruxtecan, Enhertu	University of Southampton, AstraZeneca, Natera, Inc.	Gastrooesophageal Cancer	03/26	04/28
Seneviratne, Lalith
DECIPHER, NCT05965479: Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer	Recruiting	2	25	Europe	Trastuzumab deruxtecan, Enhertu	University of Southampton, AstraZeneca, Natera, Inc.	Gastrooesophageal Cancer	03/26	04/28